[PRESENTATION] Standardization of preclinical wet AMD models

Summary: Dr. Jeff Jamison presented his take on ocular angiogenesis and relevant preclinical models at the 3rd Retinal Vascular Disease Drug Development Summit

Experimentica’s Director In Vivo Pharmacology Dr. Jeff Jamison presented his take on ocular angiogenesis and relevant preclinical models at the 3rd Retinal Vascular Disease Drug Development Summit in Boston, MA on February 22, 2023.

Specifically, Dr. Jamison discussed:

• Preclinical models for ocular angiogenesis
• The rabbit DL-AAA model for wet AMD
• Validation of suprachoroidal route of injections in preclinical species

The conference unites the industry leaders at the forefront of developing and delivering innovative treatments against retinal vascular diseases, with an unparalleled quality of technical insights on preclinical and clinical ocular drug development.

Experimentica is proud to sponsor this year’s edition of the conference. Full program available here.